Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Documenting Process Validation Studies – V 2.0

Posted on By

SOP for Documenting Process Validation Studies – V 2.0

Procedure for Documenting Process Validation Studies

Department Quality Assurance (QA)/Production/Research & Development (R&D)
SOP No. SOP/Ointment/116
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a standardized process for documenting process validation studies in ointment manufacturing. Proper documentation ensures traceability, regulatory compliance, and consistency in product quality.

2. Scope

This SOP applies to all personnel in the Quality Assurance (QA), Production, and Research & Development (R&D) departments responsible for recording, maintaining, and reviewing process validation documentation.

3. Responsibilities

  • QA Officer: Ensures proper documentation and regulatory compliance of process validation studies.
  • Production Supervisor: Provides process details and operational parameters for documentation.
  • Validation Team: Records validation parameters, testing results, and deviations.
  • R&D Scientist: Defines critical process parameters and assesses study results.
  • QA Manager: Approves process validation reports and ensures regulatory compliance.
See also  Ointments: SOP for Microbial Testing in Ointment Development - V 2.0

4. Accountability

The QA and R&D Managers are accountable for ensuring that process validation documentation aligns with GMP, FDA, ICH, and WHO guidelines.

5. Procedure

5.1 Validation Documentation Requirements

  • Process validation documentation must include:
    • Validation Plan
    • Validation Protocol
    • Raw Data Collection
    • Test Results and Acceptance Criteria
    • Deviation Reports (if applicable)
    • Final Validation Report
  • Ensure records are complete, legible, and properly signed off.

5.2 Execution of Process Validation

  • Conduct a minimum of three consecutive
validation batches to confirm process consistency.
  • Ensure that process parameters such as mixing time, temperature, and filling accuracy are documented.
  • Collect in-process samples at predefined intervals for quality testing.
  • 5.3 Data Compilation and Review

    • Compile all raw data, including:
      • Batch manufacturing records
      • Analytical test results
      • Equipment calibration logs
    • QA must review data integrity before final approval.
    • Identify any deviations and document corrective actions taken.

    5.4 Final Validation Report

    • Prepare a comprehensive validation report summarizing:
      • Validation objectives
      • Methodology
      • Summary of test results
      • Conclusion and final approval
    • Ensure that all required approvals are obtained before finalizing the report.
    • Maintain records for regulatory audits and inspections.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • ICH – International Council for Harmonisation
    • FDA – Food and Drug Administration

    7. Documents

    • Process Validation Protocol (Annexure-1)
    • Process Validation Report (Annexure-2)

    8. References

    • ICH Q8 – Pharmaceutical Development
    • WHO GMP Guidelines for Process Validation
    • FDA Guidance on Process Validation

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Process Validation Protocol

    Validation Parameter Specification Acceptance Criteria
    Batch Size 10kg – 500kg ±5% Variation
    Mixing Time 30-90 minutes No Phase Separation
    Filling Accuracy ±2% of Target Weight Compliant

    Annexure-2: Process Validation Report

    Batch Number Batch Size Homogeneity Yield Final Approval
    OINT-1601 50kg Compliant 98% QA Manager
    OINT-1602 250kg Compliant 99% QA Manager

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    See also  Ointments: SOP for Cross-Contamination Risk Assessment - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Job Safety Analysis for Fluid Bed Processor
    Next Post: Capsule: SOP for Handling and Storing Gelatin for Capsule Shell Preparation – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version